Printer Friendly
The Free Library
14,694,313 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

INSULIN INHALER TESTS NEARING A FINAL PHASE GIANT LEAP FOR MANNKIND.


Byline: Eugene Tong Staff Writer

VALENCIA - Local biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 firm MannKind Corp. has completed the second-phase trial for its experimental insulin inhalation system and will begin the final studies for federal approval by year's end.

The Valencia company said this week it recently met with the U.S. Food and Drug Administration officials to discuss plans for taking the Technosphere Insulin System into Phase 3 trials.

Insulin for diabetics is usually injected by needle and, in some cases, by a new pump system. But the technology under development allows delivery through an inhaler inhaler /in·hal·er/ (in-hal´er)
1. an apparatus for administering vapor or volatilized medications by inhalation.

2. ventilator (2).


in·hal·er
n.
.

``The discussions focused on our plans for pivotal Phase 3 clinical development, which is expected to include two years of safety data from a subset of trial patients with type 1 and with type 2 diabetes type 2 diabetes
n.
See diabetes mellitus.
 at the time of submission of a new drug application,'' Dr. Wendell Cheatham, company vice president and chief medical officer, said in a statement.

MannKind completed Phase 2 trials in October. The study, which lasted two years, examined the treatment's effectiveness. Results are slated to be released in the coming weeks.

Phase 1 trials examined general safety issues and began in the late 1990s.

Officials plan to begin phase 3 studies in Europe by year's end, and in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  by mid-2005.

The company's insulin therapy consists of a proprietary dry powder Dry Powder

A slang term for cash reserves kept on hand to cover future obligations.

Notes:
For example, if a venture capitalist expects bad times in the IPO markets you might hear him say something like, "we want to keep enough dry powder around to keep funding our
 insulin formula that is inhaled in·hale  
v. in·haled, in·hal·ing, in·hales

v.tr.
1. To draw (air or smoke, for example) into the lungs by breathing; inspire.

2.
 into the deep lung using an inhaler. The company claims their system's unique procedure and convenience holds potential change for current diabetes treatment paradigm.

Eugene Tong, (661) 257-5253

eugene.tong(at)dailynews.com
COPYRIGHT 2004 Daily News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Daily News (Los Angeles, CA)
Geographic Code:1USA
Date:Nov 14, 2004
Words:259
Previous Article:WHATEVER HAPPENED TO THE NHL?(Sports)
Next Article:VACCINE VETERANS FLU SHOTS GIVEN TO HIGH-RISK RESIDENTS.(News)



Related Articles
INSULIN INHALANT SHOWS PROMISE IN RECENT STUDY.(News)
MANNKIND POSTS Q4 LOSS HIGH CLINICAL TRIAL COSTS BLAMED.(News)
MANNKIND POSTS $22.2 MILLION LOSS BIOMED FIRM CITES INSULIN INHALER TRIALS.(News)
FIRM IN NASDAQ BIOTECH INDEX LOCAL MANNKIND CORP. CHOSEN FOR LISTING.(News)
INHALED-INSULIN TESTS PLANNED MANNKIND CORP. ENROLLING PATIENTS IN PHASE 3 SAFETY TRIAL.(News)
FUNDING FOUND FOR CLINICAL TRIAL RUN MANNKIND TO DO FINAL DIABETES-DRUG TESTING.(News)
BIOTECH ENTREPRENEUR MANN RANKED 125TH ON FORBES' LIST 79-YEAR-OLD CEO WORTH $2.1 BILLION, ACCORDING TO MAGAZINE.(News)
MannKind shares rebounding on outlook for insulin inhaler.(Company overview)
Mannkind stock soars on prospects for new drug.(Public Companies)
DIABETES SUFFERERS COULD HAVE BREATHER FROM SHOTS MANNKIND CORP. HAS PATIENTS FOR STUDY OF INSULIN THAT CAN BE INHALED.(Business)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles